The success of the SELECT trial may lead to a similar approval for Wegovy in people with obesity or overweight
C-reactive protein and inflammatory markers CRP, the most commonly measured marker of systemic inflammation, begins declining within the first three months of semaglutide treatment
Limitations of the STEP-HFpEF Trial Duration of Follow-Up: The trial followed participants for a specific period, and while it showed positive outcomes, the long-term effects of semaglutide still need to be studied over a more extended timeframe to ensure its safety and sustained effectiveness
*Correspondence: ZongRan Pang, [email protected]
However, experts such as Daniel Drucker, one of the researchers who discovered the GLP-1 hormone decades ago, believes that is about to change
Ozempic es una marca comercial de semaglutida, uno de los medicamentos GLP-1